Roxana Mehran,

Search results

• FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

  Roxana Mehran,

  4/11/21

  1 item of Media coverage

  Press/Media

• ‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

  Roxana Mehran,

  4/11/21

  1 item of Media coverage

  Press/Media

• OCT Guidance Cuts Stent Use in STEMI Without Plaque Rupture: EROSION III

  Roxana Mehran,

  4/11/21

  1 item of Media coverage

  Press/Media

• Novel Stent Gets 'Sweet' Victory in Diabetes Patients

  Gregg Stone & Roxana Mehran,

  4/11/21

  1 item of Media coverage

  Press/Media

• iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

  Roxana Mehran,

  4/11/21

  1 item of Media coverage

  Press/Media

• TCT 2021: Six-month RADIANCE-HTN TRIO results “open a window” for renal denervation

  Roxana Mehran,

  4/11/21

  2 items of Media coverage

  Press/Media

• No-Pressure-Wire Physiology Boosts PCI Outcomes

  Roxana Mehran,

  4/11/21

  1 item of Media coverage

  Press/Media

• In-Person and Online: TCT to Showcase Imaging, Valves, DCBs, and More

  Roxana Mehran,

  1/11/21

  1 item of Media coverage

  Press/Media

• EACTS 2021: Panel urges action over lack of representation of women in coronary revascularisation trials

  Roxana Mehran,

  15/10/21

  1 item of Media coverage

  Press/Media

• 1-month DAPT may be enough post-PCI

  Roxana Mehran,

  3/10/21

  1 item of Media coverage

  Press/Media

• ABILITY Diabetes Global enrols thousandth patient

  Roxana Mehran,

  10/09/21

  1 item of Media coverage

  Press/Media

• RIPCORD2: No additional benefit of systematic FFR at diagnostic angiography for chest pain

  Roxana Mehran,

  29/08/21

  1 item of Media coverage

  Press/Media

• MASTER DAPT: 1 month DAPT enough after high-bleeding-risk PCI

  Roxana Mehran,

  29/08/21

  2 items of Media coverage

  Press/Media

• European valvular heart disease guideline parses who should get TAVR or surgical AVR

  Roxana Mehran,

  28/08/21

  1 item of Media coverage

  Press/Media

• Watchful Waiting Prevails for Most With Stable Angina

  Roxana Mehran,

  15/07/21

  1 item of Media coverage

  Press/Media

• TWILIGHT: Ticagrelor monotherapy 3 months post-PCI decreases bleeding regardless of age

  Roxana Mehran,

  13/07/21

  1 item of Media coverage

  Press/Media

• Abbott's XIENCE Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk Patients

  Roxana Mehran,

  30/06/21 → 12/07/21

  11 items of Media coverage

  Press/Media

• FDA okays 1-month dual antiplatelet therapy for Abbott’s Xience stents

  Roxana Mehran,

  7/07/21

  2 items of Media coverage

  Press/Media

• Abbott Boosts DES Offerings with New Approvals

  Roxana Mehran,

  6/07/21

  1 item of Media coverage

  Press/Media

• US FDA approves Abbott's XIENCE stent to treat blood thinner course for high bleeding risk patients

  Roxana Mehran,

  3/07/21

  1 item of Media coverage

  Press/Media

• US FDA approves Abbott’s XIENCE stent to treat blood thinner course for high bleeding risk patients

  Roxana Mehran,

  2/07/21 → 3/07/21

  2 items of Media coverage

  Press/Media

• Abbott racks up 2 more US, EU approvals for Xience family of drug-eluting stents

  Roxana Mehran,

  1/07/21

  2 items of Media coverage

  Press/Media

• -ABBOTT'S XIENCE STENT RECEIVES FDA APPROVAL FOR SHORTEST BLOOD THINNER COURSE FOR HIGH BLEEDING RISK PATIENTS

  Roxana Mehran,

  1/07/21

  1 item of Media coverage

  Press/Media

• Abbott racks up 2 more U.S., EU approvals for Xience family of drug-eluting stents

  Roxana Mehran,

  1/07/21

  1 item of Media coverage

  Press/Media

• Abbott gains key DAPT approvals for Xience stents in US, Europe

  Roxana Mehran,

  30/06/21

  1 item of Media coverage

  Press/Media